Nanomedicine and Nanoscale Delivery (Focus Group – NND)
Fahima Reete, PhD student (she/her/hers)
Fahima Reete
University of Auckland
Auckland, Auckland, New Zealand
Dosing-limiting adverse effects of non-specific chemotherapy continue to pose a major clinical challenge [1]. Ultrasound (US) offers a promising external mechanism to spatially control drug release from nanocarriers at their target site [2]. Niosomes are attractive delivery systems due to their structural stability, compositional flexibility and low manufacturing cost [3]. This study explored the US-responsiveness and blood stability of various niosome compositions.